The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.

Main|Search|PHGKB

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

---

• The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.  
  European journal of human genetics : EJHG 2016 Dec .
  Kay Chris, Tirado-Hurtado Indira, Cornejo-Olivas Mario, Collins Jennifer A, Wright Galen, Inca-Martinez Miguel, Veliz-Otani Diego, Ketelaar Maria E, Slama Ramy A, Ross Colin J, Mazzetti Pilar, Hayden Michael
• Clinical manifestations of intermediate allele carriers in Huntington disease.  
  Neurology 2016 Jul .
  Cubo Esther, Ramos-Arroyo María A, Martinez-Horta Saul, Martínez-Descalls Asunción, Calvo Sara, Gil-Polo Cecilia,
• Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.  
  Journal of neurochemistry 2016 Jun .
  Rodrigues Filipe Brogueira, Byrne Lauren, McColgan Peter, Robertson Nicola, Tabrizi Sarah J, Leavitt Blair R, Zetterberg Henrik, Wild Edward
• Globus pallidus degeneration and clinico-pathological features of Huntington's disease.  
  Annals of neurology 2016 Jun .
  Singh-Bains Malvindar K, Tippett Lynette J, Hogg Virginia M, Synek Beth J, Roxburgh Richard H, Waldvogel Henry J, Faull Richard L
• Huntington disease reduced penetrance alleles occur at high frequency in the general population.  
  Neurology 2016 Jun .
  Kay Chris, Collins Jennifer A, Miedzybrodzka Zosia, Madore Steven J, Gordon Erynn S, Gerry Norman, Davidson Mark, Slama Ramy A, Hayden Michael

more